THE OB-C GROUP, LLC for ELI LILLY
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 1548, Pathway for Biosimilars Act: entire bill. HR 4872, Health Care and Education Reconciliation Act of 2010: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HR 3590: Patient Protection and Affordable Care Act; matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL S JOHNSON | — |
| THOMAS J KEATING | — |
| ROBERT H MARSH | — |
| NATHAN J MILLER | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.